Abstract:The heme oxygenase (HO) enzyme system catabolizes heme to carbon monoxide (CO), ferrous iron, and biliverdin-IXα (BV), which is reduced to bilirubin-IXα (BR) by biliverdin reductase (BVR). HO activity is represented by two distinct isozymes, the inducible form, HO-1, and a constitutive form, HO-2, encoded by distinct genes (HMOX1, HMOX2, respectively). HO-1 responds to transcriptional activation in response to a wide variety of chemical and physical stimuli, including its natural substrate heme, oxidants, and phytochemical antioxidants. The expression of HO-1 is regulated by NF-E2-related factor-2 and counter-regulated by Bach-1, in a heme-sensitive manner. Additionally, HMOX1 promoter polymorphisms have been associated with human disease. The induction of HO-1 can confer protection in inflammatory conditions through removal of heme, a pro-oxidant and potential catalyst of lipid peroxidation, whereas iron released from HO activity may trigger ferritin synthesis or ferroptosis. The production of heme-derived reaction products (i.e., BV, BR) may contribute to HO-dependent cytoprotection via antioxidant and immunomodulatory effects. Additionally, BVR and BR have newly recognized roles in lipid regulation. CO may alter mitochondrial function leading to modulation of downstream signaling pathways that culminate in anti-apoptotic, anti-inflammatory, anti-proliferative and immunomodulatory effects. This review will present evidence for beneficial effects of HO-1 and its reaction products in human diseases, including cardiovascular disease (CVD), metabolic conditions, including diabetes and obesity, as well as acute and chronic diseases of the liver, kidney, or lung. Strategies targeting the HO-1 pathway, including genetic or chemical modulation of HO-1 expression, or application of BR, CO gas, or CO donor compounds show therapeutic potential in inflammatory conditions, including organ ischemia/reperfusion injury. Evidence from human studies indicate that HO-1 expression may represent a biomarker of oxidative stress in various clinical conditions, while increases in serum BR levels have been correlated inversely to risk of CVD and metabolic disease. Ongoing human clinical trials investigate the potential of CO as a therapeutic in human disease.

Advances on Human Heme Oxygenase-1 Research

Hypoxia And Heme Oxygenases: Oxygen Sensing And Regulation Of Expression

Hypoxia and Heme Oxygenases: Oxygen Sensing and Regulation of Expression.

Advances in Studies on the Cytoprotection of Heme Oxygenase-1

Research progress of heme oxygenase-1 non-enzymatic activity

Role of Heme Oxygenase- 1 in Cardioprotection Against Anoxia/reoxygenation Induced Injury and Its Mechanisms

Heme oxygenase 1 in erythropoiesis: an important regulator beyond catalyzing heme catabolism

Research Progress in Effects of Heme Oxygenase-1 on Hepatoma

Biological Function of Heme Oxygenase in Its Role in Liver Transplantation

Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions

Heme oxygenase-1 and research progress in tumor

The Nuclear Translocation of Heme Oxygenase-1 in Human Diseases

[Hho-1 Structure Prediction and Its Mutant Construct, Expression, Purification and Activity Analysis].

Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications

The roles of heme oxygenase-1 in renal disease

Heme Oxygenase System and Its Role Played in Asthma

The Biological Function of Heme Oxygenase

Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders

The non-canonical effects of heme oxygenase-1, a classical fighter against oxidative stress

The Role of Heme Oxygenase-1 in T Cell-Mediated Immunity: the All Encompassing Enzyme.

Heme oxygenase-1 and carbon monoxide in pulmonary medicine